Several years ago, a little-known drug named Ozempic — previously used only to treat diabetes — emerged as a promising new ...
With with GLP-1 drugs, gastrointestinal issues, such as nausea, vomiting, constipation, and gastroesophageal reflux disease, ...
ArisEurope, ICON, Syneos Health, Accenture, IQVIA, Genpact, Cognizant, Paraxel International, Laboratory Corporation of ...
Biogen Inc. (NASDAQ:BIIB), a leading biopharmaceutical company specializing in neurology and rare diseases, finds itself at a critical juncture as it navigates a complex landscape of opportunities and ...
The guidelines support use of PPIs, dietary therapy, and biologics for EoE, and stress the importance of addressing both the ...
Pharma: Launch of Shortages Monitoring Platform, several Changes re Clinical Trial Management in EU Countries; Devices: Resolution on the need ...
The European Medicines Agency (EMA) announced that it will review 2 Danish studies which indicate there may be a link between semaglutide injection drug Ozempic (Novo ... 2 “These new register-based ...
the Critical Path Institute, the Food and Drug Administration (FDA) and the European Medicines Agency (EMEA; now EMA). These studies provide data supporting the utility of seven renal biomarkers ...
CNN on MSN12d
Red dye No. 3 is now banned in the US. Here’s what studies show about more common dyesMade from petroleum and chemically known as erythrosine, red dye No. 3 is a synthetic color additive used to give foods and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback